Skip to main contentDr Harsh Shah · Pancreas Cancer Surgeon · Apollo Hospital, Bhat, Gandhinagar and Gota OPD, Ahmedabad
Most pancreatic cysts are found by accident, on a scan ordered for something else — gas, back pain, a stone, a health check. The report says cyst, or cystic lesion, and from that moment two opposite mistakes become possible. One is to remove it: pancreatic surgery is among the largest operations in the abdomen, and performing it for a cyst that would never have harmed anyone is a serious harm rather than a cautious choice. The other is to forget it — a few of these lesions are already turning into cancer, and they are curable only while someone is still watching. Naming the cyst is almost the whole of the work, and Dr Harsh Shah does it at Shah’s Gastro, Cancer & Robotic Surgery Centre with MRI, endoscopic ultrasound and cyst-fluid testing before surveillance or surgery is discussed at all.
Shah’s Gastro, Cancer & Robotic Surgery Centre
Dr Harsh Shah
MS, MCh (Surgical Gastroenterology), DrNB (Surgical Gastroenterology)
Pancreas Cancer Surgeon
· Apollo Hospital, Bhat, Gandhinagar · Gota OPD, Ahmedabad
Qualified twice over in surgical gastroenterology and trained in high-volume units, Dr Harsh Shah runs a pancreas service that does both halves of this problem — the operations, and the unglamorous business of watching a lesion properly for years. A cyst decision needs a radiologist who reads pancreatic MRI regularly, an endoscopist who can needle a small lesion safely, and a surgeon with no reason to operate unless the lesion earns it. Google rating 4.89 from 216 reviews at the Gota clinic, and 4.94 from 17 at the Apollo Hospital, Bhat listing.
Cyst is not a diagnosis. It is a shape on a scan, and at least six different things make that shape — some essentially harmless, others carrying a real risk of becoming cancer. The type, not the size, decides what follows: a serous cystadenoma the size of a lemon can be left alone, while a main-duct lesion far smaller is removed in anyone fit for surgery.
| What it is | Who tends to have it, and what it looks like | What it means |
|---|---|---|
| Branch-duct IPMN | Older patients, usually in the head, often several at once, connected to the pancreatic duct, grape-like in clusters | Risk is low but real, and depends entirely on the features below |
| Main-duct or mixed IPMN | The main pancreatic duct itself widened, mucus visible coming from the drainage opening at endoscopy | High risk. Removed in anyone fit for an operation |
| Mucinous cystic neoplasm (MCN) | Middle-aged women, body or tail, a single cyst, no connection to the duct | Moderate risk. Removed if large, symptomatic, or showing a nodule |
| Serous cystadenoma | Older women, a honeycomb of tiny cysts, sometimes a scar at the centre | Essentially harmless. Neither removed nor watched indefinitely once the diagnosis is confident |
| Cystic neuroendocrine tumour | A brightly enhancing rim | Treated on the neuroendocrine pathway |
| Pseudocyst | Follows an attack of pancreatitis; fluid rich in amylase | Not a tumour at all — but never assume this without a convincing history of pancreatitis |
MRI with MRCP is the scan of choice, not CT. It shows the shape of the cyst, whether it connects to the pancreatic duct, whether the wall carries a nodule, and how wide the main duct is — and because it uses no radiation it can be repeated for as long as a patient needs watching. Where the diagnosis remains uncertain, endoscopic ultrasound goes further: nothing else shows a small nodule as reliably, and nothing else can draw fluid out for testing.
What is done with that fluid has changed, and many laboratories are still working the old way. Cyst-fluid glucose is now the better test for a mucinous cyst — a level below 50 mg/dL points to one — and it beats CEA, costs very little and runs in any laboratory, so where CEA is being sent alone, adding glucose costs almost nothing. Amylase in the fluid says the cyst communicates with the duct. Molecular testing helps where it is available — GNAS is close to specific for IPMN, and TP53 or SMAD4 suggest a lesion that has already advanced. Cytology is worth having but is not evidence of safety: a clear result here usually means the needle missed.
Two checks belong in the same visit. CA 19-9 is recorded, because a rise in it warns rather than diagnoses. HbA1c is recorded, because diabetes appearing for the first time in someone who has a pancreatic cyst is treated here as a feature of the cyst, not a coincidence of middle age. A family history of pancreatic cancer, and any known inherited cancer syndrome, are written down at the first visit, because they change how closely the lesion is followed.
Some features call for an operation in anyone fit for one; others call for a closer look with endoscopic ultrasound. Dr Harsh Shah works to the Kyoto 2024 criteria, which replaced the 2017 Fukuoka set — a pathway, referral form or radiology template still naming Fukuoka is out of date.
Three findings put an operation on the table straight away, in a patient fit for it: jaundice caused by a cystic lesion in the head of the pancreas; a nodule on the cyst wall that takes up contrast and measures 5 mm or more; and a main pancreatic duct of 10 mm or wider.
A longer list calls for endoscopic ultrasound and a tumour board discussion rather than a decision on the spot: a cyst of 30 mm or more; a contrast-taking nodule under 5 mm; a thickened or contrast-taking wall; a main duct of 5 to 10 mm; an abrupt narrowing of the duct with the gland beyond it shrunken; enlarged lymph nodes; a rising CA 19-9; growth of 2.5 mm or more in a year; new or suddenly worse diabetes; and pancreatitis the cyst itself explains.
Where none is present, watching is the correct treatment, not a compromise.
For a branch-duct IPMN with none of the worrying features, the treatment is a schedule of MRI scans, and the interval is set by the size of the cyst. Under 20 mm: a scan at six months, then every eighteen months while it stays unchanged. Between 20 and 30 mm: yearly, alternating with endoscopic ultrasound where that is available. At 30 mm or more, which is itself a worrying feature: endoscopic ultrasound and MRI every six months.
Two rules make the difference between a schedule that protects someone and one that only looks like it does. The first is that each scan is read against the previous one, not on its own — the rate at which a cyst grows carries more weight than the number it has reached, which is why old films matter and should be brought or sent. The second is that surveillance is lifelong for as long as a patient would still be fit for an operation, and stopping it is a decision to be taken openly and written down, with the reason. It is not something that should simply lapse.
The commonest failure in this disease is not a misread scan. It is a patient who feels completely well, misses one appointment and then another, and returns years later with jaundice — a system failing rather than a patient failing, which is why a tracked register with a named person responsible for recalling people is part of the treatment here rather than an optional extra. Watching also does not end at five years for a stable cyst, and it does not end after surgery for an IPMN, because the remaining gland stays at risk. The one exception is a mucinous cystic neoplasm removed completely and found not to be invasive.
The operation follows where the cyst sits. In the head or uncinate part it is a pancreatoduodenectomy — the Whipple operation. In the body or tail it is a distal pancreatectomy, with one important difference from cancer surgery: for a benign or low-grade lesion the spleen can usually be preserved, whereas in an established adenocarcinoma it comes out with the specimen.
The consent conversation here is unlike the one for cancer, and Dr Harsh Shah holds it personally, because this patient may feel entirely well. Pancreatic surgery carries a real risk of death, of leak from the join, of bleeding, of slow stomach emptying and of permanent change to digestion and blood sugar; the figures that apply to your own age, fitness and anatomy are given at that discussion, in your own language and with your family present, rather than on a web page. Two things are said in advance rather than explained afterwards: the final diagnosis is known only once the specimen has been examined, and it may prove entirely benign. That is the accepted consequence of operating on risk instead of certainty.
Both paths cost money, and they cost it differently. Surveillance is a repeating expense — an MRI at intervals for years — and outpatient imaging is often covered less generously than an admission, so the policy terms are worth checking early. Surgery is planned work, so cashless pre-authorisation is completed before admission by the office at Apollo Hospital, Bhat, and CGHS and corporate panels go through the same office. An itemised written estimate is given before you commit. Room category, length of stay, whether endoscopic ultrasound comes first, which operation is performed and whether the spleen is preserved all move that estimate, so a single figure quoted over the phone by anyone is a guess.
★★★★★
“We consulted Dr Harsh shah for my Husband as having cyst . surgery was done by Doctor very successfully. today we got discharged. our experience with sir was very good . he is very cooperative, explained about diagnosis very calmly. well Experienced, good Doctor . also thanks to Roshani maam for good cooperation. Thanks sir Dr Priyanka Prajapati”
★★★★★
“We are very thankful to Dr. Harsh Shah for successfully performing the Whipple’s procedure. From the beginning, he explained everything clearly and gave us great confidence throughout the treatment. Today, we are happy to share that we received the discharge and are going home with a positive feeling. Thank you, Dr. Harsh Shah, for your expertise, care, and support. Highly recommended for GI surgery.”
★★★★★
“In my opinion, Dr. Harsh Shah is the best pancreatic cancer specialist in Ahmedabad. He has operated on my mother who was suffering from neuroendocrine tumor of pancreas. The operation called distal pancreatectomy was done. Now my mother is fine and we are being discharged today. I would say that we have been given the best treatment for pancreatic cancer. Thanks to all the staff of the hospital. I would highly recommend Dr. Harsh Shah for any treatment for pancreatic cancer.”
— Priyanka Prajapati, Google review, Apollo Hospital, Bhat listing
— Desai Sonal, Google review, Apollo Hospital, Bhat listing
— Darji Monika, Google review, Gota clinic listing (translated by Google from the original Gujarati)
The video is in English. The anatomy in it is what decides whether a cyst means a Whipple, a distal pancreatectomy with the spleen preserved, or nothing.
Usually not. Several of the common types are harmless, and a serous cystadenoma needs neither an operation nor indefinite watching once the diagnosis is confident. Two types do carry a real risk of turning, which is why a cyst has to be named rather than measured. Until it is named, neither reassurance nor alarm is justified.
Draining is the treatment for a pseudocyst — fluid left after an attack of pancreatitis, not a tumour. Draining a mucinous cyst achieves nothing lasting, because the lining that makes the fluid stays behind. That is why calling a cyst a pseudocyst without a convincing history of pancreatitis is a consequential error.
For as long as you would still be fit for an operation, because a change caught during surveillance can be treated and one found later often cannot. It is not stopped at five years for a stable cyst, and when it is stopped — for age, other illness or fitness — that is discussed with you and written in the record with the reason.
It depends how much of the gland comes out. A parenchyma-sparing removal takes very little insulin-producing tissue, a distal pancreatectomy takes more, and removing the whole gland means insulin for life. It is one of the main reasons an operation is not advised for a lesion that has not earned it.
If the lesion was an IPMN, the gland that was left behind carries the same tendency, so watching continues after the operation. The exception is a mucinous cystic neoplasm removed completely and found not to be invasive — that one needs no further surveillance, and being told so plainly is part of the treatment.
Shah’s Gastro, Cancer & Robotic Surgery Centre
Gota, Ahmedabad, Gujarat
Google rating 4.89 from 216 reviews
Dr Harsh Shah consults at two addresses: the clinic at Gota, Ahmedabad, and Apollo Hospital at Bhat, Gandhinagar.
Patients travel here from across Gujarat and from Rajasthan and Madhya Pradesh. Because a cyst decision rests on comparing today’s scan with the older ones, images sent ahead allow the reading and the plan in one visit — and a surveillance schedule can then run from home, with only the scan done locally.
Holding a report that mentions a pancreatic cyst? Send the images, not only the report — the film shows things the words leave out. Call +91-63555-64601 · WhatsApp Dr Harsh Shah's office
Swasth Parivar: twice a month, practical advice on recovery, diet and warning signs. No advertising. Stop any time.
Your number is used for these updates and for the clinic to reach you. It is never sold or passed on. To stop, reply STOP on WhatsApp.
